Peptide Glossary and Laboratory Terminology

How to use this glossary

Peptide records combine chemistry, analytical science, quality systems and logistics. The same word can be used differently across laboratories, so a project should define critical terms in its method or specification. These concise definitions support orientation and document review. They do not override pharmacopeial definitions, validated procedures, accreditation scopes or product-specific records.

A

Acceptance criterion

A documented limit, range or qualitative requirement that a result must meet for a material, method, system or process to be accepted.

Accuracy

The closeness of a measured result to an accepted reference value. Accuracy is distinct from precision, which describes agreement among repeated measurements.

Acetate salt

A form in which acetate acts as a counter-ion associated with charged peptide groups. Salt form can influence mass calculations, solubility and composition.

Adduct

An ion or molecular species formed when an analyte associates with another component, such as sodium, potassium or solvent, often visible in mass spectra.

Aggregation

Association of peptide molecules into dimers, oligomers or larger assemblies. Aggregation can be reversible or irreversible and can alter assay behaviour.

Aliquot

A measured portion transferred from a parent sample or stock. Aliquots can reduce repeated handling but introduce transfer, adsorption and labelling risks.

Amino acid

An organic building block containing amino and carboxyl functionality. Peptide sequences are assembled from amino-acid residues connected by peptide bonds.

Amino-acid analysis

An analytical approach that hydrolyses or otherwise measures constituent amino acids to support composition or quantitative peptide-content assessment under defined conditions.

Amphipathic

Having both hydrophilic and hydrophobic regions. Amphipathic peptides may interact strongly with membranes, interfaces, columns and container surfaces.

Analytical method

A documented procedure for measuring an attribute, including sample preparation, apparatus, conditions, calculations, controls and system-suitability requirements.

Analyte

The chemical species or property intended to be detected or quantified in a sample.

Assay

A quantitative procedure used to estimate amount, concentration, content or activity. Assay should not be used as a synonym for chromatographic purity.

Audit trail

A secure, time-linked record of actions and changes affecting electronic data, helping reviewers reconstruct who did what and when.

B

Batch

A defined quantity produced or processed under intended uniform conditions and identified by a unique number or code for traceability.

Batch record

The controlled collection of manufacturing, processing, packaging, testing, review and release information associated with a specific batch.

Blank

A sample containing no intended analyte, used to evaluate background, contamination, carryover or interference from reagents and the analytical system.

Buffer

A solution designed to resist pH change. Buffer identity, strength and additives can affect peptide solubility, stability, binding and metal coordination.

C

Calibration curve

A relationship between instrument response and known analyte concentrations used to estimate concentration in samples within a defined range.

Capillary electrophoresis

A separation method using an electric field in a narrow capillary. It can provide information complementary to liquid chromatography for some peptides.

CAS Registry Number

A numerical identifier assigned by Chemical Abstracts Service to a registered substance. It does not replace sequence or form verification for peptides.

Certificate of Analysis

A batch-specific document summarising material identity, tests, results and authorised review. Its scope and method detail determine how it can be used.

Chain of custody

A documented history of sample possession, transfer, storage and handling intended to protect identity and accountability from collection through disposition.

Chromatogram

A plot of detector response against time or volume during chromatographic separation. Peaks require method context and controlled integration for interpretation.

Chromatography

A family of separation techniques in which components distribute differently between a stationary phase and a moving phase.

Cold chain

A controlled temperature pathway through storage and transport. A tracked parcel is not a verified cold chain without suitable qualification and temperature evidence.

Concentration

The amount of a component per quantity of mixture or solution, expressed on a clearly stated mass, molar, volume or other basis.

Contamination

Unintended chemical, particulate, microbiological or cross-product material introduced into a sample, container, process or environment.

Control sample

A material or condition used to establish expected performance, background or comparison. Controls should be appropriate to the specific experimental question.

Counter-ion

An oppositely charged ion associated with charged peptide groups, such as acetate or trifluoroacetate. It can influence composition and molecular calculations.

Critical quality attribute

A physical, chemical, biological or microbiological property that should remain within an appropriate limit to support the intended research use.

Cysteine

A sulphur-containing amino acid whose thiol can form disulfide bonds or undergo oxidation. Cysteine state can be central to peptide structure.

D

Deamidation

A chemical change affecting amide-containing residues such as asparagine or glutamine, potentially producing mass, charge and chromatographic changes.

Degradation product

A species formed when the target material changes during manufacture, handling, storage or analysis through chemical or physical pathways.

Deletion sequence

A synthesis-related peptide variant missing one or more intended amino-acid residues, commonly arising from incomplete coupling during stepwise synthesis.

Desiccant

A moisture-absorbing material included in suitable packaging to reduce humidity exposure. It does not compensate for a leaking or repeatedly opened container.

Detection limit

The lowest analyte level that can be reliably distinguished from background under stated method conditions, without necessarily supporting accurate quantitation.

Detector wavelength

The light wavelength monitored by a UV detector. Peptide and impurity responses can differ with wavelength, affecting relative chromatographic areas.

Disulfide bond

A covalent link formed between two cysteine sulphur atoms. Correct disulfide connectivity can be essential to peptide conformation and function.

Dissolution

The process by which material disperses at the molecular or ionic level in a solvent. Visual clarity alone does not prove complete recovery.

E

Endotoxin

Lipopolysaccharide material associated with Gram-negative bacteria that can strongly affect biological assays. Low chemical impurity does not establish low endotoxin.

Excipient

A non-target component intentionally included in a formulation, such as a buffer, bulking agent or stabiliser. Excipients should be declared where relevant.

Expiry date

A date through which a material is expected to meet defined requirements when stored as specified, supported by an appropriate stability programme.

External standard

A separately prepared reference used to calibrate or compare an analytical response rather than being added directly to each sample.

F

Fmoc solid-phase peptide synthesis

A stepwise synthesis strategy using fluorenylmethoxycarbonyl protection while the growing peptide remains attached to a solid support.

Formula weight

The calculated mass associated with a chemical formula unit. For salts, hydrates or mixtures, the reporting basis must be stated.

Freeze-thaw cycle

One complete freezing and thawing event. Repeated cycles can change aggregation, concentration uniformity, container integrity or chemical stability.

G

Gradient elution

A chromatographic programme in which mobile-phase composition changes over time to alter retention and separate components with different properties.

Gross mass

The total measured mass of supplied material, potentially including peptide, counter-ion, water and declared excipients. It is not automatically net peptide content.

H

Half-life

The time required for an amount or concentration to decrease by half under defined conditions. Chemical stability and biological pharmacokinetic half-lives differ.

High-performance liquid chromatography

An instrument-based separation technique using pressurised mobile phase and a packed column, widely applied to peptide purity and method-development work.

HPLC purity

Usually the relative integrated area assigned to a principal chromatographic peak. It does not by itself establish identity, assay, sterility or total composition.

Hydrolysis

Chemical bond cleavage involving water. Peptide bonds and susceptible side-chain or terminal modifications can undergo hydrolytic degradation under some conditions.

Hydrophilic

Having affinity for water or polar environments. Hydrophilicity influences solubility, chromatography, membrane interaction and surface adsorption.

Hydrophobic

Having affinity for non-polar environments. Hydrophobic sequences may show stronger reversed-phase retention, aggregation or surface interaction.

I

Identity

Evidence that a material is the chemical entity it is represented to be. Identity may require mass, sequence or orthogonal analytical confirmation.

Impurity

A component other than the intended material or declared formulation components. Impurities can arise from synthesis, purification, degradation or contamination.

In vitro

An experiment performed outside a living organism, commonly in a cell-free system, cultured cells or isolated tissue under controlled conditions.

In vivo

An experiment performed in a living organism. Species, model, formulation and exposure limit how findings can be translated.

Integration

The process of defining and calculating chromatographic peak area. Integration settings and manual changes can materially affect reported purity.

Internal standard

A known compound added to samples and calibrators to help correct for preparation, injection or instrument variability in quantitative analysis.

Ion-pair reagent

A mobile-phase additive that associates with charged analytes and alters chromatographic retention. Trifluoroacetic acid is commonly used in peptide methods.

L

LC-MS

Liquid chromatography coupled to mass spectrometry, combining separation with mass-to-charge detection to support peptide identity and impurity investigation.

Limit of quantitation

The lowest analyte level that can be measured with suitable accuracy and precision under the method’s stated conditions.

Lot

A traceability term often used interchangeably with batch, although an organisation’s quality system should define its exact usage.

Lyophilisation

Freeze-drying, in which frozen solvent is removed mainly by sublimation under reduced pressure. Lyophilisation does not guarantee indefinite stability.

M

MALDI

Matrix-assisted laser desorption/ionisation, a mass-spectrometry ionisation technique that can analyse peptides after co-crystallisation with a suitable matrix.

Mass accuracy

The closeness of an observed mass or mass-to-charge value to the expected value, commonly expressed in daltons or parts per million.

Mass spectrum

A plot of ion signal against mass-to-charge ratio. Charge states, isotopes, adducts and fragments must be considered during interpretation.

Mass-to-charge ratio

The ratio, written m/z, between an ion’s mass and its charge number. Multiply charged peptides can produce several related signals.

Matrix effect

Alteration of analytical response caused by other sample components, often through ion suppression, enhancement, binding or interference.

Method qualification

Documented evidence that a method performs adequately for a defined purpose, generally less comprehensive or formal than full validation.

Method validation

A structured demonstration that a method is fit for its intended purpose across relevant performance characteristics and operating conditions.

Molarity

Amount of substance in moles per litre of solution. Reliable molarity requires a justified molecular form and content basis.

Molecular formula

A notation showing the elements and atom counts in a molecule or formula unit. Salt, hydration and modification state affect the formula.

Molecular weight

The relative molecular mass calculated from constituent atoms, often reported as an average mass unless monoisotopic mass is specified.

Monoisotopic mass

The exact mass calculated using the lightest predominant isotope of each element, useful when interpreting high-resolution mass spectra.

N

Net peptide content

The estimated amount of peptide after accounting for relevant non-peptide mass such as water, counter-ion or excipients using defined measurements.

Nominal quantity

The labelled or target amount assigned during filling or formulation. It may not be equivalent to an independently measured assay result.

O

Orthogonal method

An analytical approach based on a different measurement principle, used to provide complementary evidence and reduce shared method bias.

Oxidation

A chemical process involving loss of electrons or reaction with oxidising species. Methionine, cysteine and tryptophan can be vulnerable peptide residues.

P

Peptide

A molecule containing amino-acid residues joined by peptide bonds. Practical boundaries between peptides and proteins vary by context.

Peptide bond

The amide linkage formed between the carboxyl group of one amino acid and the amino group of another.

Peptide content

The proportion or amount attributable to peptide rather than water, counter-ions, residuals or excipients, determined on a stated analytical basis.

pH

A logarithmic measure related to hydrogen-ion activity. pH can affect peptide charge, solubility, conformation, degradation and metal binding.

Precision

The closeness of agreement among repeated measurements under specified conditions. Good precision does not by itself establish accuracy.

Preclinical research

Laboratory and animal work conducted before or outside controlled human clinical evaluation. Preclinical findings do not establish human safety or efficacy.

Purity

The degree to which a material is free from specified impurities under a stated measurement method. Purity must always identify its basis.

Q

Quality assurance

Planned, systematic activities intended to provide confidence that quality requirements are defined, implemented, reviewed and improved.

Quality control

Operational testing and checks used to determine whether materials, methods or outputs meet defined requirements.

Quarantine

A controlled status preventing routine use of material until review, testing or investigation supports an authorised disposition decision.

R

Reference standard

A well-characterised material used as a basis for identity, purity or quantitative comparison. Its qualification and intended use should be documented.

Relative peak area

A chromatographic peak area expressed as a proportion of selected total integrated area. Detector response differences limit direct composition interpretation.

Residual solvent

An organic volatile remaining from synthesis, purification or processing. Dedicated gas-chromatographic or other suitable methods may be required.

Retention time

The elapsed time between sample introduction and a chromatographic peak’s detection under specified conditions. It supports comparison but is not unique identity.

Retest date

A date at which a stored material should be re-examined against defined criteria before continued use, rather than automatically discarded.

Reversed-phase chromatography

A liquid-chromatography mode using a relatively non-polar stationary phase and more polar mobile phase, widely used for peptide separations.

Robustness

The capacity of a method to remain reliable during small, deliberate variations in operating parameters.

Research Use Only

A supply boundary indicating laboratory investigation rather than human or veterinary use. It is not a universal regulatory exemption.

S

Salt form

The ionic form in which a peptide is supplied, defined by associated counter-ions. Salt form can affect formula, mass, solubility and handling.

Sample identifier

A unique code linking a tested sample to its source, batch, preparation and analytical records.

Sequence

The ordered arrangement of amino-acid residues. Sequence notation should also define termini, modifications and disulfide connectivity where relevant.

Sequence variant

A peptide differing from the intended sequence through substitution, deletion, insertion, truncation or modification.

Shelf life

The supported period during which a product is expected to meet specifications under stated packaging and storage conditions.

Signal-to-noise ratio

A comparison of analyte signal with background variation, commonly used when evaluating detection and quantitation capability.

Solubility

The amount of material that can form a solution under specified solvent, temperature, pH and composition conditions.

Solvent

A liquid medium used to dissolve or disperse components. Solvent identity and grade can influence stability, recovery and assay compatibility.

Specification

A documented set of requirements for identity, tests, limits, packaging, storage or other attributes that a material is expected to meet.

Spike recovery

The proportion of a known added analyte amount measured after sample preparation, used to assess loss and matrix effects.

Stability-indicating method

A method capable of measuring the target while resolving relevant degradation products or changes under the conditions being studied.

Sterility

The absence of viable microorganisms as demonstrated through an appropriate sterility assurance and test framework. HPLC purity does not imply sterility.

Stock solution

A prepared solution of defined concentration used to make working solutions. Its content basis, solvent, stability and storage must be documented.

System suitability

Predefined checks demonstrating that an analytical system performs adequately before or during sample analysis.

T

TFA

Trifluoroacetic acid, used in peptide synthesis and chromatography and often present as a counter-ion. Its amount may matter in sensitive experiments.

Traceability

The ability to follow the history, application or location of a material or result through documented identifiers and records.

Truncation

A sequence variant missing residues from one end or another defined portion, potentially arising during synthesis or degradation.

U

Uncertainty of measurement

A parameter expressing dispersion reasonably attributable to a measured value. It helps users judge whether results support a decision near a limit.

UV detection

Measurement of ultraviolet absorbance during chromatography. Peptide-bond and aromatic-residue responses depend on wavelength and composition.

V

Validation

Documented evidence that a method, process or system consistently fulfils requirements for its specified intended use.

Vehicle control

An experimental condition containing the same solvent, buffer and additives as the test preparation but without the target peptide.

W

Water content

The amount of water in a material, measurable by methods such as Karl Fischer titration. Water contributes mass not represented by peptide purity.

Working standard

A reference used routinely after comparison or qualification against a higher-order reference standard.

Y

Yield

The amount recovered from a process relative to the theoretical or starting amount. Yield does not establish identity or purity.

Continue learning

Apply these terms using the HPLC batch testing guide, storage protocol and complete research peptide guide. For internationally recognised laboratory competence principles, consult ISO/IEC 17025 information. For biomedical literature, search PubMed and record the exact query and review date.